Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
How Should We Be Taking Advantage of Neoadjuvant Endocrine Therapy? ER+ MBC: Where Do We Stand Today in Terms of PFS and OS? Key Differences Among the 3 CDK4/6
Login to view comments.
Click here to Login
